首页> 中文期刊> 《中国药物评价》 >纳洛酮和单唾液酸四己糖神经节苷脂治疗颅脑损伤的间接Meta分析

纳洛酮和单唾液酸四己糖神经节苷脂治疗颅脑损伤的间接Meta分析

         

摘要

目的:系统评价纳洛酮和单唾液酸四己糖神经节苷脂(GM1)治疗颅脑损伤的疗效。方法:以间接Meta分析的方法对已有研究进行合并,系统评价两种药物治疗颅脑损伤的GOS恢复良好率。结果:纳洛酮和GM1的GOS恢复良好率分别为69.15%和55.61%。结论:在治疗颅脑损伤的GOS恢复良好率方面,纳洛酮明显优于GM1。%Objective: To systematically evaluate the efficacy of curative effects of treating head injury between naloxone and GM1.Methods:GOS good recovery rate was taken as effectiveness indicator.An indirect Meta-analysis was developed.Results:The GOS good recovery rates are 69.15%and 55.61%for naloxone and GM1 respectively.Conclusion:The research showed that GOS good recov-ery rate in naloxone arm is better than that in GM 1 arm.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号